Aligos Therapeutics Inc. buy BiotechBee
Start price
14.07.24
/
60%
€0.47
Target price
28.02.26
€1.00
Performance (%)
-8.43%
End price
08.09.24
-
Summary
This prediction is currently being closed. With a performance of -8.43%, the BUY prediction for Aligos Therapeutics Inc. by BiotechBee is down slightly. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Aligos Therapeutics Inc. | - | - |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
According to BiotechBee what are the pros and cons of Aligos Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Aligos Therapeutics Inc. diskutieren
Buy mit Kursziel 1,0
In the thread Trading Aligos Therapeutics Inc.
Buy beendet
Stopped prediction by BiotechBee for Aligos Therapeutics Inc.
Aligos Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.06
03.03.24
03.03.24
€3.00
30.04.26
30.04.26
-55.80%
14.07.24
14.07.24
Could be very worthwhile Investment >20% year